Gokhan Tut
Overview
Explore the profile of Gokhan Tut including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krutikov M, Bone D, Stirrup O, Bruton R, Azmi B, Fuller C, et al.
Wellcome Open Res
. 2024 Oct;
8:553.
PMID: 39364338
VIVALDI (ISRCTN14447421) is a government-funded longitudinal open observational cohort study of staff and residents in care homes for older people in England. The study aimed to describe epidemiology (including seroprevalence)...
2.
Stirrup O, Tut G, Krutikov M, Bone D, Lancaster T, Azmi B, et al.
Wellcome Open Res
. 2024 May;
9():45.
PMID: 38818129
Background: We have previously demonstrated that older residents of long-term care facilities (LTCF) in the UK show levels of anti-spike antibodies that are comparable to the general population following primary...
3.
Dowell A, Tut G, Begum J, Bruton R, Bentley C, Butler M, et al.
J Infect
. 2023 Sep;
87(5):403-412.
PMID: 37660754
Repeated coronavirus infections in childhood drive progressive maturation of systemic immune responses into adulthood. Analyses of immune responses in children have focused primarily upon systemic assessment but the importance of...
4.
Stirrup O, Shrotri M, Adams N, Krutikov M, Azmi B, Monakhov I, et al.
Age Ageing
. 2023 Aug;
52(8).
PMID: 37595069
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused severe disease in unvaccinated long-term care facility (LTCF) residents. Initial booster vaccination following primary vaccination is known to provide strong short-term...
5.
Tut G, Lancaster T, Krutikov M, Sylla P, Bone D, Spalkova E, et al.
Nat Aging
. 2023 Apr;
3(1):93-104.
PMID: 37118525
Third-dose coronavirus disease 2019 vaccines are being deployed widely but their efficacy has not been assessed adequately in vulnerable older people who exhibit suboptimal responses after primary vaccination series. This...
6.
Tut G, Lancaster T, Butler M, Sylla P, Spalkova E, Bone D, et al.
Nat Aging
. 2023 Apr;
2(6):536-547.
PMID: 37118449
We studied humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 152 long-term care facility staff and 124 residents over a prospective 4-month period shortly after...
7.
Stirrup O, Shrotri M, Adams N, Krutikov M, Nacer-Laidi H, Azmi B, et al.
Open Forum Infect Dis
. 2023 Jan;
10(1):ofac694.
PMID: 36713473
Background: Successive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have caused severe disease in long-term care facility (LTCF) residents. Primary vaccination provides strong short-term protection, but data are limited...
8.
Tut G, Lancaster T, Sylla P, Butler M, Kaur N, Spalkova E, et al.
Lancet Healthy Longev
. 2022 Jul;
3(7):e461-e469.
PMID: 35813280
Background: Older age and frailty are risk factors for poor clinical outcomes following SARS-CoV-2 infection. As such, COVID-19 vaccination has been prioritised for individuals with these factors, but there is...
9.
Shrotri M, Krutikov M, Nacer-Laidi H, Azmi B, Palmer T, Giddings R, et al.
Lancet Healthy Longev
. 2022 Jul;
3(7):e470-e480.
PMID: 35813279
Background: Residents and staff in long-term care facilities have been prioritised for vaccination against SARS-CoV-2, but data on potential waning of vaccine effectiveness and the effect of booster doses in...
10.
Parry H, Bruton R, Roberts T, McIlroy G, Damery S, Sylla P, et al.
Cancer Cell
. 2022 May;
40(6):584-586.
PMID: 35588735
No abstract available.